News | April 26, 2012

New AHA Mission: Heart Attack Referring/Receiving Center Accreditation

April 26, 2012 - The timing of treatment when someone is having a heart attack can mean the difference between life and death. To help save lives, the American Heart Association (AHA) and the Society of Chest Pain Centers joined forces in September 2011 to improve the care of patients suffering from the most deadly type of heart attack, known as an ST-elevation myocardial infarction (STEMI). The American Heart Association’s Mission: Lifeline Heart Attack Referring/Receiving Center Accreditation program recognizes hospitals for their ability to quickly and appropriately treat heart attack patients.

In an effort to improve the processes surrounding the care of the STEMI heart attack patient, the American Heart Association launched Mission: Lifeline in 2007. Mission: Lifeline provides tools and resources to hospitals and EMS agencies with the goal of making systems of care more efficient to help improve the overall quality-of-care received by each STEMI patient. Mission: Lifeline systems start with the 9-1-1 call or at entry into the emergency system, continues through the catheterization laboratory and through hospital discharge by promoting best practices that are identified using the very latest scientific evidence-based treatment for STEMI. Through this new program, accreditation is granted to hospitals that meet the American Heart Association’s Mission: Lifeline defined standards for prompt diagnosis and treatment of a STEMI heart attack.

“Heart disease is the leading cause of death in the United States, claiming more than 616,000 lives each year.” said Gordon Tomaselli, M.D., president of the American Heart Association. “By taking steps to significantly reduce cardiac death in patients through education of early heart attack symptoms, reducing time for life-saving treatment and increasing the accuracy and effectiveness of treatment administered, the American Heart Association’s Mission: Lifeline Heart Attack Referring/Receiving Accreditation program will help save lives in hospitals across the country.”

Since the program’s inception, 10 hospitals located in various parts of the country, including Kansas, Kentucky, North Carolina, Ohio, Texas and Virginia, have been recognized with this accreditation.

The facilities have been recognized for meeting the standards of quality care by using the very latest scientific evidence-based treatment for heart attack patients. All centers that have received accreditation will now be able to proudly display the new American Heart Association Mission: Lifeline Heart Attack Referring/Receiving Center Heart-Check mark that will help patients easily identify the facility as one of quality and trust.

For more information: www.heart.org/myhospital orwww.scpcp.org

Related Content

Tryton Side Branch Stent Recognized With Premier Technology Breakthrough Award
News | Stents Bifurcation| September 21, 2017
September 21, 2017 — Cardinal Health and Tryton Medical Inc.
DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Peter Schneider, M.D. presents late breaking clinical trial results at VIVA 17 in Las Vegas. Panelists (l to r) Krishna Rocha-Singh, M.D., Sean Lyden, M.D., John Kaufman, M.D., Donna Buckley, M.D.

Feature | Cath Lab| September 14, 2017
September 14, 2017 — Here are quick summaries for all the key late-breaking vascular and endovascular clinical trials
Mississippi Surgical and Vascular Center Uses Toshiba Ultimax-i FPD to Save Patients' Limbs
News | Angiography| September 14, 2017
The southern U.S. sees some of the highest numbers of chronic medical conditions, such as peripheral artery disease...
Sponsored Content | Videos | Structural Heart Occluders| September 13, 2017
Ziyad Hijazi, M.D., MPH, MSCAI, FACC, director of the cardiac program and chair of the Department of Pediatrics at Si
Philips Showcases Integrated Vascular Solutions at VIVA 2017
News | Peripheral Artery Disease (PAD)| September 13, 2017
Philips announced its presence at the Vascular Interventional Advances (VIVA 17) Annual Conference in Las Vegas from...
Overlay Init